KPV, a peptide patented by L'Oreal, may promote hair growth and reduce hairloss by extending the anagen phase and has anti-inflammatory properties. It could be combined with treatments like minoxidil for enhanced effects.
Sugary beverages increase the risk of pattern hairloss in men by 57%, and type 2 diabetes is linked to female pattern hairloss. Reducing sugar intake and using treatments like finasteride and minoxidil may help manage hairloss.
Hairloss without a white bulb may indicate mechanical damage, anagen effluvium, alopecia areata, or traction alopecia. Seeking a specialist is recommended, but access can be difficult in smaller areas.
Treatments for hairloss, such as topical minoxidil, platelet-rich plasma therapy with or without minoxidil, ketoconazole, non-abative radio frequency, natural products, finasteride and cortexolone 17 alpha propionate. The post evaluates the efficacy and safety of these treatments in various studies.
PP405 is a new hairloss treatment in phase 2 trials that may promote hair growth by increasing lactate production and activating hair follicle stem cells. It could potentially replace hormone-disrupting treatments like Minoxidil and finasteride.